Ibalizumab Targeting CD4 Receptors, An Emerging Molecule in HIV Therapy
Author:
Publisher
Frontiers Media SA
Subject
Microbiology (medical),Microbiology
Reference60 articles.
1. Antibody-drug conjugates, targeted drug delivery for cancer;Alley;Curr. Opin. Chem. Biol.,2010
2. Passive immunization with the anti-HIV-1 human monoclonal antibody (hMAb) 4E10 and the hMAb combination 4E10/2F5/2G12;Armbruster;J. Antimicrob. Chemother.,2004
3. A phase I trial with two human monoclonal antibodies (hMAb 2F5, 2G12) against HIV-1;Armbruster;AIDS,2002
4. Choices in IgG replacement therapy for primary immune deficiency diseases, subcutaneous IgG vs. intravenous IgG and selecting an optimal dose;Berger;Curr. Opin. Allergy Clin. Immunol,2011
5. Ibalizumab, an anti-CD4 monoclonal antibody for the treatment of HIV-1 infection;Bruno;J. Antimicrob. Chemother.,2010
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Identification of potential therapeutic drugs targeting core genes for systemic lupus erythematosus (SLE) and coexisting COVID‐19: Insights from bioinformatic analyses;Immunity, Inflammation and Disease;2023-11
2. A review of immune modulators and immunotherapy in infectious diseases;Molecular and Cellular Biochemistry;2023-09-08
3. Efficacy and Safety of Two-Drug Regimens That Are Approved from 2018 to 2022 for the Treatment of Human Immunodeficiency Virus (HIV) Disease and Its Opportunistic Infections;Microorganisms;2023-05-31
4. SIV clearance from neonatal macaques following transient CCR5 depletion;2023-05-01
5. New Antiretroviral Agents for HIV Infection;New Antimicrobials: For the Present and the Future;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3